BMS-986177 (JNJ-70033093)

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986177 (JNJ-70033093), covering 2022-07-15 to 2022-07-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery [Phase 2]

See pricing